Literature DB >> 6693015

Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas.

D F Schafer, S C Pappas, L E Brody, R Jacobs, E A Jones.   

Abstract

The recording of visual evoked potentials in rabbits has been shown to be an objective, reproducible, noninvasive technique for quantitating changes in the pattern of cerebral neuronal activity. The development of hepatic encephalopathy due to galactosamine-induced fulminant hepatic failure was consistently associated with a series of distinctive changes in the visual evoked potential waveform. The pattern of the visual evoked potential in hepatic coma (due to galactosamine-induced fulminant hepatic failure) differed fundamentally from that in ether-induced coma, but was identical to that in comas induced by three drugs which activate gamma-aminobutyric acid-ergic neural mechanisms: pentobarbital, diazepam, and muscimol. These findings are compatible with activation of the gamma-aminobutyric acid inhibitory neurotransmitter system contributing to cerebral neuronal inhibition in hepatic coma due to galactosamine-induced fulminant hepatic failure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693015

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

Review 1.  Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure?

Authors:  E A Jones; A S Basile
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  EEG and event related potentials in hepatic encephalopathy.

Authors:  M G Davies; M J Rowan; J Feely
Journal:  Metab Brain Dis       Date:  1991-12       Impact factor: 3.584

Review 3.  Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.

Authors:  J D Rothstein; M Olasmaa
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

4.  Cortical benzodiazepine receptor binding in a rabbit model of hepatic encephalopathy: the effect of Triton X-100 on receptor solubilization.

Authors:  M Rössle; K D Mullen; E A Jones
Journal:  Metab Brain Dis       Date:  1989-09       Impact factor: 3.584

5.  Evidence for the presence of a benzodiazepine receptor binding substance in cerebrospinal fluid of a rabbit model of hepatic encephalopathy.

Authors:  K D Mullen; J V Martin; W B Mendelson; K Kaminsky-Russ; E A Jones
Journal:  Metab Brain Dis       Date:  1989-12       Impact factor: 3.584

6.  Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil.

Authors:  H P Meyer; D A Legemate; W van den Brom; J Rothuizen
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

7.  Effects of inhibition of ornithine aminotransferase on thioacetamide-induced hepatogenic encephalopathy.

Authors:  S Sarhan; B Knödgen; C Grauffel; N Seiler
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

Review 8.  Flumazenil in the treatment of portal systemic encephalopathy--an overview.

Authors:  K Gyr; R Meier
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

9.  Plasma concentrations of endogenous benzodiazepine-receptor ligands in patients with hepatic encephalopathy: a comparative study.

Authors:  C A Hernández-Avila; W J Shoemaker; H A Ortega-Soto
Journal:  J Psychiatry Neurosci       Date:  1998-09       Impact factor: 6.186

10.  Postsynaptic gamma-aminobutyric acid receptors in hepatic coma following portacaval shunt and hepatic artery ligation in the rat.

Authors:  P Ferenci; L Zieve; J Ebner; C Zimmermann; D Rzepczynski
Journal:  Metab Brain Dis       Date:  1987-09       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.